Clinical Trials Browser

NCT07515963 2026-04-07

FULIRI Plus Targeted Therapy for First-line Conversion Therapy of Colorectal Cancer Liver Metastases.

Phase 2 Not yet recruiting

24 enrolled

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT07510932 2026-04-06

FIRST-K

Phase 2 Not yet recruiting

88 enrolled

Gastrointestinal

Colonic Neoplasms

NCT07409844 2026-02-20

RESET C2

Phase 2 Not yet recruiting

152 enrolled

Gastrointestinal

Colonic Neoplasms

NCT07405476 2026-02-12

Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

Phase 2 Not yet recruiting

38 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT07224022 2026-02-04

NACho

Phase 2 Not yet recruiting

24 enrolled

Gastrointestinal

Colonic Neoplasms

NCT07178717 2025-09-17

REFISH

Phase 2 Not yet recruiting

25 enrolled

Gastrointestinal

Colonic Neoplasms

NCT07156682 2025-09-05

QL1706 Plus XELOX as Neoadjuvant Therapy for MSS/pMMR Clinical Stage III Colon Cancer

Phase 2 Not yet recruiting

21 enrolled

Gastrointestinal

Colonic Neoplasms

NCT07058012 2025-07-10

EMPIRE

Phase 2 Not yet recruiting

79 enrolled

Gastrointestinal

Colonic Neoplasms

NCT06646445 2025-06-13

PREMICES

Phase 2 Not yet recruiting

60 enrolled

Gastrointestinal

Turcot syndrome, Colonic Neoplasms, Microsatellite Instability

NCT06999252 2025-05-31

Rimegepant Combined With PD-1 in Liver Metastasis Colorectal Cancer Patients

Phase 2 Not yet recruiting

20 enrolled

Gastrointestinal

Colonic Neoplasms

NCT06890624 2025-03-27

OPTICAL-3

Phase 2 Not yet recruiting

138 enrolled

Gastrointestinal

Colonic Neoplasms

NCT06790212 2025-03-17

Neoadjuvant CAPOX Plus Ivonescimab Versus CAPOX for Locally Advanced Colon Cancer

Phase 2 Not yet recruiting

168 enrolled

Gastrointestinal

Colonic Neoplasms

NCT06665087 2024-10-30

CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC

Phase 2 Not yet recruiting

110 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT06652412 2024-10-28

CGA Guided Ultrafractionated RT and Systemic Treatment in Elderly or Frail Patients with Inoperable Localized CRC

Phase 2 Not yet recruiting

124 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT06594692 2024-09-19

mRCAT-C

Phase 2 Not yet recruiting

140 enrolled

Gastrointestinal

Colonic Neoplasms, Spinocerebellar Degenerations

NCT06491355 2024-07-09

First-Line Treatment Induced With mFOLFOX6 and HLX04 Regimen, Following Combined With Serplulimab in MSS Initially Unresectable Metastatic Colorectal Cancer

Phase 2 Not yet recruiting

72 enrolled

Gastrointestinal

Colonic Neoplasms

NCT06255379 2024-04-29

Study of Fruquintinib Combined With Tegafur Gimeracil Oteracil in Patients With Metastatic Colorectal Cancer

Phase 2 Not yet recruiting

52 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT06301386 2024-03-08

Everolimus Combined With PD-1 in Advanced Colorectal Cancer Patients

Phase 2 Not yet recruiting

25 enrolled

Gastrointestinal

Colonic Neoplasms

NCT06218888 2024-01-23

A Phase II Clinical Study of the Efficacy and Safety of Tislelizumab Combined With Fruquintinib and Chidamide in the Treatment of Unresectable or Advanced Microsatellite Stabilized (MSS/pMMR) Colorectal Cancer With Liver Metastases

Phase 2 Not yet recruiting

17 enrolled

Gastrointestinal

Colonic Neoplasms

NCT05231850 2022-02-09

A Phase II Study of Tislelizumab as Adjuvant Therapy for Patients With Stage Ⅱ and Stage Ⅲ Colon Cancer and dMMR/MSI.

Phase 2 Not yet recruiting

70 enrolled

Gastrointestinal

Colonic Neoplasms